131 related articles for article (PubMed ID: 23510893)
1. Substraction acetazolamide SPECT co-registered to MRI in moyamoya disease: quantitative cerebrovascular reserve map.
Cortés J; Arias-Rivas S; Rodriguez-Yañez M; Blanco M; Aguiar P
Clin Nucl Med; 2014 Apr; 39(4):399-401. PubMed ID: 23510893
[TBL] [Abstract][Full Text] [Related]
2. Which CT perfusion parameter best reflects cerebrovascular reserve?: correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in Moyamoya patients.
Rim NJ; Kim HS; Shin YS; Kim SY
AJNR Am J Neuroradiol; 2008 Oct; 29(9):1658-63. PubMed ID: 18617583
[TBL] [Abstract][Full Text] [Related]
3. SPECT and MRI evaluations of the posterior circulation in moyamoya disease.
Yamada I; Murata Y; Umehara I; Suzuki S; Matsushima Y
J Nucl Med; 1996 Oct; 37(10):1613-7. PubMed ID: 8862293
[TBL] [Abstract][Full Text] [Related]
4. CT perfusion imaging for childhood moyamoya disease before and after surgical revascularization.
Sakamoto S; Ohba S; Shibukawa M; Kiura Y; Arita K; Kurisu K
Acta Neurochir (Wien); 2006 Jan; 148(1):77-81; discussion 81. PubMed ID: 16184319
[TBL] [Abstract][Full Text] [Related]
5. Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT.
Hoshi H; Ohnishi T; Jinnouchi S; Futami S; Nagamachi S; Kodama T; Watanabe K; Ueda T; Wakisaka S
J Nucl Med; 1994 Jan; 35(1):44-50. PubMed ID: 8271059
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cerebral hemodynamics with perfusion MRI in childhood moyamoya disease.
Kim SK; Wang KC; Oh CW; Kim IO; Lee DS; Song IC; Cho BK
Pediatr Neurosurg; 2003 Feb; 38(2):68-75. PubMed ID: 12566838
[TBL] [Abstract][Full Text] [Related]
7. Acetazolamide-challenged perfusion magnetic resonance imaging for assessment of cerebrovascular reserve capacity in patients with symptomatic middle cerebral artery stenosis: comparison with technetium-99m-hexamethylpropyleneamine oxime single-photon emission computed tomography.
Kim HJ; Kim TW; Ryu SY; Yang PS; Kwon MJ; Kim JC; Lee YS; Lee HJ; Yang JH; Kim JK; Chung YA; Oh EY; Lee SB
Clin Imaging; 2011; 35(6):413-20. PubMed ID: 22040783
[TBL] [Abstract][Full Text] [Related]
8. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging.
Noguchi T; Kawashima M; Irie H; Ootsuka T; Nishihara M; Matsushima T; Kudo S
Eur J Radiol; 2011 Dec; 80(3):e557-62. PubMed ID: 21315533
[TBL] [Abstract][Full Text] [Related]
9. Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease.
Inoue Y; Momose T; Machida K; Honda N; Tsutsumi K
J Nucl Med; 1993 Nov; 34(11):1984-6. PubMed ID: 8229245
[TBL] [Abstract][Full Text] [Related]
10. Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease.
Marushima A; Tsurushima H; Suzuki K; Nakai Y; Nemoto H; Matsumura A
World Neurosurg; 2011; 76(3-4):304-10. PubMed ID: 21986429
[TBL] [Abstract][Full Text] [Related]
11. Cerebral-perfusion-based single-photon emission computed tomography (SPECT) staging using NeuroGam® in patients with moyamoya disease.
Han JH; Park YS; Lee WH; Koong SS; Min KS; Lee MS; Kim YG; Kim DH; Yi KS; Cha SH
Childs Nerv Syst; 2016 Aug; 32(8):1471-7. PubMed ID: 26661381
[TBL] [Abstract][Full Text] [Related]
12. SPECT measurements of cerebral blood volume before and after acetazolamide in occlusive cerebrovascular diseases.
Inoue Y; Momose T; Machida K; Honda N; Nishikawa J; Sasaki Y
Radiat Med; 1994; 12(5):225-9. PubMed ID: 7863027
[TBL] [Abstract][Full Text] [Related]
13. Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery.
So Y; Lee HY; Kim SK; Lee JS; Wang KC; Cho BK; Kang E; Lee DS
Stroke; 2005 Jul; 36(7):1485-9. PubMed ID: 15947261
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of cerebral perfusion abnormalities in moyamoya disease using susceptibility perfusion- and diffusion-weighted MRI.
Adams WM; Laitt RD; Li KL; Jackson A; Sherrington CR; Talbot P
Neuroradiology; 1999 Feb; 41(2):86-92. PubMed ID: 10090600
[TBL] [Abstract][Full Text] [Related]
15. Extensive brain infarction involving deep structures during an acetazolamide-challenged single-photon emission computed tomography scan in a patient with moyamoya disease.
Chong S; Park JD; Chae JH; Cheon JE; Kim SK; Phi JH; Lee JY; Paeng JC; Wang KC
Childs Nerv Syst; 2017 Nov; 33(11):2029-2033. PubMed ID: 28689345
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of perfusion-weighted MRI for evaluating postoperative alteration of cerebral hemodynamics following STA-MCA anastomosis in patients with moyamoya disease].
Fujimura M; Mugikura S; Shimizu H; Tominaga T
No Shinkei Geka; 2006 Aug; 34(8):801-9. PubMed ID: 16910493
[TBL] [Abstract][Full Text] [Related]
17. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cerebral blood flow reserve in patients with cerebrovascular disease by SPECT using technetium-99m-L, L-ethyl cysteinate dimer.
Hori A; Harada M; Nishitani H; Uno M
J Med Invest; 2002 Aug; 49(3-4):134-41. PubMed ID: 12323002
[TBL] [Abstract][Full Text] [Related]
19. Moyamoya disease associated with Behcet's disease.
Joo SP; Kim TS; Lee JH; Lee JK; Kim JH; Kim SH; Kim MK; Cho KH
J Clin Neurosci; 2006 Apr; 13(3):364-7. PubMed ID: 16581493
[TBL] [Abstract][Full Text] [Related]
20. The clinical features of adult unilateral moyamoya disease: does it have the same clinical characteristics as typical moyamoya disease?
Ogata T; Yasaka M; Inoue T; Yasumori K; Ibayashi S; Iida M; Okada Y
Cerebrovasc Dis; 2008; 26(3):244-9. PubMed ID: 18648196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
